HIGHLIGHTS
- who: Jonas Asku00f8 Andersen from the Borgmester Ib Juuls Vej, Herlev, Denmark have published the research work: Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate safety of treating diabetic foot ulcers with a topically administered mesenchymal stem cell product. The aim of the study was to evaluate the safety of the IMP, which was done by monitoring incidence and causality of adverse events (AEs) and SAEs observed in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.